Open AccessThe Role of CYP2C9 Gene Polymorphisms on Anticoagulant Therapy after Heart Valve Replacement
Author(s) -
Hatice Kalkan Yı̇ldırım,
Lülüfer Tamer,
Nehir Sucu,
Uğur Atik
Publication year - 2008
Publication title -
medical principles and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 45
eISSN - 1423-0151
pISSN - 1011-7571
DOI - 10.1159/000151568
Subject(s) - medicine , anticoagulant therapy , cyp2c9 , valve replacement , warfarin , heart valve replacement , anticoagulant , cardiology , genetic enhancement , heart valve , gene , bioinformatics , atrial fibrillation , intensive care medicine , genetics , biology , stenosis , cytochrome p450 , metabolism
The aim of the present study was to investigate the role of CYP2C9 gene polymorphisms after heart valve replacement in a group of patients on warfarin therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom